Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues
Reexamination Certificate
1999-01-15
2002-09-17
Caputa, Anthony C. (Department: 1642)
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
C530S345000, C530S350000, C530S402000
Reexamination Certificate
active
06451969
ABSTRACT:
FIELD OF THE INVENTION
The present invention relates to novel peptides and methods of inhibiting tumor metastasis.
BACKGROUND OF THE INVENTION
Selectins are cell-surface carbohydrate binding proteins that mediate cell adhesion between leukocytes and the vascular endothelial surface. For example, binding of E-selectin to its ligand expressed on the surface of circulating neutrophils initiates rolling, and an early step in the recruitment of these cells to a site of injury or inflammation. Several potential therapeutics have been tested for their ability to inhibit adhesion of E-selectin to neutrophils, including carbohydrate-based molecules, antibodies, soluble E-selectin, and selectin-Ig chimeras. While these molecules have been useful to show the utility of selectin blockers for treating inflammation, each has significant shortcomings as a therapeutic, including short in vivo half-life, potential immunogenicity, high cost, and other side effects. A further drawback of these approaches is the lack of an efficient means to improve the pharmaceutical properties of these various molecules.
Cancer is a leading cause of death in developing countries. It is known that metastatic spread of cancer cells can not be prevented by surgery. Growing evidence suggests that carbohydrate-mediated cancer cell adhesion to selectins on the vascular endothelium is involved in the metastasis of a wide variety of epithelial cancers, including gastric, colorectal, pancreatic, liver, ovary, head and neck, and breast cancers. However, methods of effectively inhibiting carbohydrate-mediated cancer cell adhesion to selectins on the vascular endothelium are lacking.
Recent advances in methods for the preparation and screening of large numbers of individual peptides has led to the identification of numerous peptides useful in all areas of biomedical research, including research regarding the interaction of ligands to cell surface molecules. Even with these advances, however, compounds that effectively inhibit tumor metastasis are lacking. Thus, a need exists for compounds useful to treat cancer by inhibiting metastasis. This invention satisfies these needs and provides related advantages as well.
BRIEF DESCRIPTION OF THE INVENTION
In accordance with the present invention, there are provided peptides that bind to a member of the mammalian selectin family and inhibit the binding of a carbohydrate to said selectin. Invention peptides are useful to inhibit of the adhesion of cells containing particular cell-surface carbohydrates to cells containing cell-surface selectins.
Also provided in accordance with the present invention are pharmaceutical compositions comprising invention peptides useful in methods for inhibiting a carbohydrate from binding to a selectin, and in methods of inhibiting tumor cell metastasis and inflammation in a subject.
REFERENCES:
patent: 4631211 (1986-12-01), Houghten
patent: 5064655 (1991-11-01), Uster et al.
patent: 5223409 (1993-06-01), Ladner et al.
patent: 5728802 (1998-03-01), Barrett et al.
patent: WO 98/53071 (1998-11-01), None
Murakami, Y. et al. Analysis of the nucleotided sequence of chromosome VI fromSaccharomyces cerevisiae. Nature Genetics, 10: 261-268, Jul. 1995.*
Accession No. Q57497, Database SPTREMBL, Everisss, K.D. et al., Nov. 1996.*
Heerze et al., “Utilization of sialic acid-binding synthetic peptide sequences derived from pertussis toxin as novel anti-inflammatory agents,”Glycobiology5(4):427-433 (1995).
Martens et al., “Peptides which bind to E-selectin and block neutrophil adhesion,”J. Biol. Chem.270(36):21129-21136 (1995).
Morikawa et al., “Treatment of focal cerebral ischemia with synthetic oligopeptide corresponding to lectin domain of selectin,”Stroke27(5):951-955 (1996).
Rozdzinski et al., “Prokaryotic peptides that block leukocyte adherence to selectins,”J. Exp. Med.178:917-924 (1993).
Stone et al., “P-selectin mediates adhesion of platelets to neuroblastoma and small cell lung cancer,”J. Clin. Invest.92:804-813 (1993).
Aboud-Pirak et al., “Cytotoxic Activity of Daunorubicin or Vindesin Conjugated to A Monoclonal Antibody on Cultured MCF-7 Breast Carcinoma Cells,”Biochem. Pharmacol.38:641-648 (1989).
Anostario et al., “A Ligand Binding Assay for E-Selectin,”Anal. Biochem.221:317-322 (1994).
Berg et al., “A Carbohydrate Domain Common to Both Sialyl Leaand Sialyl LexIs Recognized by the Endothelial Cell Leukocyte Adhesion Molecule ELAM-1,”J. Biol. Chem.266:14869-14872 (1991).
Bevilacqua et al., “Endothelial Leukocyte Adhesion Molecule 1: An Inducible Receptor for Neutrophils Related to Complement Regulatory Proteins and Lectins,”Science243:1160-1165 (1989).
Bodansky M.,Principles of Peptide Synthesis2nd ed. (Springer-Verlag) 1988 and (1993 Supp.) Title page only.
Briand et al., “Application and limitations of the multiple antigen peptide (MAP) system in the production and evaluation of anti-peptide and anti-protein antibodies,”J. Immunol. Meth.156:255-265 (1992).
Dillman et al., “Significance of antigen, drug, and tumor cell targets in the preclinical evaluation of doxorubicin, methotrexate, and mitomycin-C monoclonal antibody immunoconjugates,”Mol. Biother.1:250-255 (1989).
Dyson et al., “The Physical Basis for Induction of Protein-Reactive Antipeptide Antibodies,”Ann. Rev. of Biophysics and Biophysical Chem.17:305-324 (1988).
Fitzpatrick and Garnett, “Studies on the mechanism of action of an MTX-HSA-MoAb conjugate, ”Anti-Cancer Drug Des.10:11-24 (1995).
Fitzpatrick and Garnett, “Design, synthesis and in vitro testing of methotrexate carrier conjugates linked via oligopeptide spacers,”Anti-Cancer Drug Des.10:1-9 (1995).
Goldman et al., “Targeted gene delivery to Kaposi's sarcoma cells via the fibroblast growth factor receptor1,”Cancer Res.15:1447-1451 (1997).
Henn et al., “Synthesis of 2'—Deoxyuridine and 5-Fluoro-2'-deoxyuridine Derivatives and Evaluation in Antibody Targeting Studies,”J. Med. Chem.36:1570-1579 (1993).
Irimura et al., “Colorectal cancer metastasis determined by carbohydrate-mediated cell adhesion: role of sialyl-Lexantigens,”Cancer Biol.4:319-324 (1993).
Johnston et al., “Cloning of GMP-140, a Granule Membrane Protein of Platelets and Endothelium: Sequence Similarity to Proteins Involved in Cell Adhesion and Inflammation,”Cell56:1033-1044 (1989).
Kannagi R., “Carbohydrate-mediated cell adhesion involved in hematogenous metastasis of cancer,”Glycoconjugate J.4:577-584 (1997).
Krauer et al., “Antitumor Effect of 2'-Deoxy-5-fluorouridine Conjugates against a Murine Thymoma and Colon Carcinoma Xenografts,”Cancer Res.52:132-137 (1997).
Kukowska-Latallo et al., “A cloned human cDNA determines expression of a mouse stage-specific embryonic antigen and the Lewis blood group &agr; (1,3/1,4) fucosyltransferase,”Genes&Develop.4:1288-1303 (1990).
Laskey et al., “Cloning of a Lymphocyte Homing Receptor Reveals a Lectin Domain,”Cell56:1045-1055 (1989).
Martín-Satué et al., “Enhanced Expression of &agr;(1,3)-Fucosyltransferase Genes Correlates with E-selectin-mediated Adhesion and metastatic Potential of Human Lung Adenocarcinoma Cells1,”Cancer Res.58:1544-1550 (1989).
McEver R.P., “Selectin-carbohydrate interactions durning inflammation and metastasis,”Glycoconjugate J.4:585-591 (1997).
Miyasaka M., “Cancer Metastasis and Adhesion Molecules,”Clin. Orthop.312:10-18 (1995).
Nakamori et al., “Increased Expression of Sialyl LewisxAntigen Correlates with Poor Survial in Patients with Colorectal Carcinoma: Clinicopathological and Immunohistochemical Study1,”Cancer Res.53:3632-3637 (1993).
Nakashio et al., “The Association of Metastasis with the Expression of Adhesion Molecules in Cell Lines Derived from Human Gastric Cancer,”Anticancer Res.17:293-300 (1997).
Nelson et al., “Higher-Affinity Oligosaccharide Ligands for E-Selectin,”J. Clin. Invest.91:1157-1166 (1993).
Pelton et al., “Conformationally restricted analogs of somatostatin with high &mgr;-opiate receptor specificity,”Proc. Natl. Acad. Sci. USA82:236-239 (1985).
Rees et al., Protein Engineering: A Practical Approach IRL Press 1992 Table of contents only.
Rowland et al., “Preclini
Fukuda Michiko
Fukuda Minoru
Campbell & Flores LLP
Canella Karen A.
Caputa Anthony C.
The Burnham Institute
LandOfFree
Methods for inhibiting tumor metastasis, and peptides useful... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for inhibiting tumor metastasis, and peptides useful..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for inhibiting tumor metastasis, and peptides useful... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2869202